Organization · Venture Studio
Next Sequence®
Next Sequence® is a venture studio that supports startups at the intersection of artificial intelligence and biology, operating globally in over 15 countries. They focus on pre-seed to Series A stages, leveraging AI and Quantum Computing.
Overview
What Next Sequence® does
What Next Sequence® is
Next Sequence® is a venture studio that supports startups at the intersection of artificial intelligence and biology, operating globally in over 15 countries. They focus on pre-seed to Series A stages, leveraging AI and Quantum Computing.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Studio
- Structured capabilities
- Funder · Program host
- Last reviewed
- March 5, 2026
What Venture studio means
A venture studio is an organization that systematically creates new startups by generating or sourcing ideas, validating them, building early products, recruiting founders or operators, providing shared resources, and retaining meaningful equity in the companies it helps create.
Open the glossary entryOfficial channels
Find Next Sequence® elsewhere
Open the official website or a supported primary organization account.
Capability profile
Next Sequence® as a funder
Investment thesis
Next Sequence® invests in startups that integrate artificial intelligence and biology, providing them with essential resources and a vast network of investors.
Focus narrative
The organization invests in startups that align with its vision of integrating artificial intelligence and biology. Their initiatives include the AI x BIO Program and the Quantum x BIO Program, which delve into the convergence of these fields. By providing access to infrastructure, cloud services, and fundraising support, Next Sequence® connects startups with a network of over 5,000 investors.
Value beyond capital
Next Sequence® adds value to its portfolio companies by providing access to critical infrastructure, cloud services, and a robust fundraising network. Their extensive connections with over 5,000 investors facilitate opportunities for startups to secure funding and scale effectively.
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Notable portfolio companies include NeuroX1, focused on genomics; ArgenTAG, specializing in DNA storage; Biomemory, engaged in drug development; PentaBind, working in biomanufacturing; Eden Bioscience, involved in bioscience innovations; FemTech, focusing on women's health technologies; Matricis AI, developing AI-driven solutions; and ImmunoMind, concentrating on immunology-related advancements.
Capability profile
Next Sequence® as a program host
Program thesis
Next Sequence® aims to foster innovations that integrate artificial intelligence with biological advancements, providing startups with essential resources and a vast network of investors.
Focus narrative
The focus of Next Sequence® is on startups that align with their vision of integrating artificial intelligence and biology. They provide tailored programs that explore the synergies between these fields, ensuring that participating startups have the resources and support needed to thrive.
Value and support
Founders participating in Next Sequence®'s programs gain access to a robust network of over 5,000 investors, infrastructure, cloud services, and fundraising support, all designed to help them scale their innovations effectively.
Availability
- Application state
- Not published
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A
- Regions
- Global · North America
Alumni and track record
Alumni context
Notable alumni companies include NeuroX1, focused on genomics; ArgenTAG, specializing in DNA storage; Biomemory, engaged in drug development; PentaBind, working in biomanufacturing; Eden Bioscience, involved in bioscience innovations; FemTech, focusing on women's health technologies; Matricis AI, developing AI-driven solutions; and ImmunoMind, concentrating on immunology advancements.
Common questions
What to know about Next Sequence®
Upseed classifies Next Sequence® under the Venture Studio organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.